Since its establishment in 2008, CHINA MIGO INDUSTRIAL CO., LIMITED has been committed to providing high-standard and high-quality active pharmaceutical ingredients (APIs) to global pharmaceutical companies. From humble beginnings to steady progress, we have weathered challenges while maintaining our reverence for quality and pursuit of innovation. Our core business focuses on the research, development, production, and sales of chemical APIs, intermediates, and pharmaceutical preparations. The company has established an international-standard and continuously improving quality management system, adhering to the quality policy of "Quality First, Customer Supreme, Striving for Excellence, Pursuing Perfection". We implement full life cycle management throughout the entire process from drug research, production, distribution to usage, ensuring the safety, stability, and efficacy of our products. Since 2008, our company has successively passed international certifications from China's NMPA, the US FDA, and the EU EDQM. With the endorsement of these international authoritative certifications, our products have entered global markets and are exported to more than 50 countries and regions, contributing Chinese strength to the practice of building a global community of health for all.
Establishment of CHINA MIGO INDUSTRIAL CO., LIMITED, initially focusing on R&D and production of API (Active Pharmaceutical Ingredients).
Formation of core management team and commissioning of the first production facility.
Obtained National Drug Production License.
Successful development and commercial launch of the first core product.
Expansion of production lines and construction of GMP-compliant facilities.
Obtained international official certifications from NMPA, FDA, and EDQM.
Product line expanded to include anti-diabetic, anti-cancer, cardiovascular, and antibiotic drugs.
Established advanced formulation R&D team and introduced sophisticated analysis and testing equipment.
Establishment of provincial-level technology research center.
API products passed international GMP certification.
Successfully entered high-end international markets in North America, Europe, and Japan.
Obtained ISO14001 Environmental Management System certification, implementing green production practices.
Commissioning of smart factory project to build a globally leading API production base with intelligent and green technologies.
Achieved technological breakthroughs in High Potency Active Pharmaceutical Ingredients (HPAPI) and other fields.
Awarded "Five-star Enterprise," "AAA Credit Rating in Pharmaceutical Industry," and "Local Tax Contribution Award."
Total workforce exceeds 300, with R&D personnel accounting for 30%.